Fundraising Fox

Nucleo Tech

1 known investors

NucleoTech engineers BrainPortal carrier proteins that attach to therapeutic antibodies and oligonucleotides and transport them across the blood-brain barrier non-invasively, using a direct in vivo screening platform to test many candidates simultaneously. It advances internal CNS therapeutics and licenses its carriers to pharma and biotech partners.

BiotechDeep TechHealthtech

Founders & leadership

UB
Uriah BekensteinCo-Founder & CEO
NC
Naftali CohenCo-Founder & CBO
AK
Adi KoplovitzCo-Founder & COO
SD
Shachar DaganHead of Research

Investors · 1

The Innovation SpaceWilmington · $200K

Competitors · 1

by search overlap
Novotech5 shared keywordsNovotech is a contract research organization (CRO) that provides clinical trial execution and scientific advisory services for biotech and biopharma sponsors, including complex cell and gene therapy trials. It has a strong regional focus on the Asia-Pacific market.

Companies competing with Nucleo Tech for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Nucleo Tech do?
NucleoTech engineers BrainPortal carrier proteins that attach to therapeutic antibodies and oligonucleotides and transport them across the blood-brain barrier non-invasively, using a direct in vivo screening platform to test many candidates simultaneously. It advances internal CNS therapeutics and licenses its carriers to pharma and biotech partners.
Who founded Nucleo Tech?
Nucleo Tech was founded by Uriah Bekenstein, Naftali Cohen, Adi Koplovitz.
Who are Nucleo Tech's investors?
Nucleo Tech's investors include The Innovation Space.